Singulair

E468961

Singulair is a prescription leukotriene receptor antagonist (montelukast) commonly used to prevent and manage asthma and allergy symptoms.

Try in SPARQL Jump to: Statements Referenced by

Statements (48)

Predicate Object
instanceOf brand name drug
pharmaceutical drug
actsOn cysteinyl leukotriene receptor CysLT1 NERFINISHED
boxedWarning risk of serious neuropsychiatric events
brandNameOf montelukast
commonSideEffect abdominal pain
cough
headache
upper respiratory infection
contraindication hypersensitivity to montelukast
dosageForm chewable tablet
film-coated tablet
oral granules
dosingFrequency once daily
drugClass anti-asthmatic agent
leukotriene receptor antagonist
respiratory system drug
eliminationRoute biliary excretion
firstApprovalRegion United States NERFINISHED
hasActiveIngredient montelukast sodium
hasATCCode R03DC03
hasBlackBoxWarningRegion United States NERFINISHED
hasGenericName montelukast
indication asthma prophylaxis
chronic asthma management
exercise-induced bronchoconstriction prevention
perennial allergic rhinitis
seasonal allergic rhinitis
lactationUse caution advised
marketingAuthorizationHolder Merck & Co. NERFINISHED
mechanismOfAction inhibits leukotriene-mediated bronchoconstriction
reduces airway inflammation
selective leukotriene receptor antagonist
metabolism hepatic
metabolizingEnzyme CYP2C9 NERFINISHED
CYP3A4 NERFINISHED
notForUse acute asthma attacks relief
onsetOfAction within hours
pregnancyCategory data suggest low risk but use if clearly needed
regulatoryStatus prescription only
routeOfAdministration oral
seriousSideEffect agitation
depression
neuropsychiatric events
suicidal thoughts
targetPopulation adults with asthma
children with asthma
patients with allergic rhinitis

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Merck & Co. notableDrug Singulair